Frazier Lifesciences Acquisition Operating Income

Frazier Lifesciences Acquisition (FLAC) currently reports a operating income of $-5.1M as of September 2022. That compares with $-1M in the prior-year period — down 389.1% year over year. Use the charts on this page to explore Frazier Lifesciences Acquisition's operating income history and peer comparisons.

Frazier Lifesciences Acquisition's operating income decreased from $-1M to $-5.1M — a 389.1% year-over-year decrease (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Frazier Lifesciences Acquisition reported $-5.1M in operating income as of September 2022. That compares with $-1M in the prior-year period — down 389.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-5.1M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Frazier Lifesciences Acquisition, and consider following FLAC for alerts when major investors trade the stock.